Germany Tweaks Health-Insurance Reform to Reduce Impact on Drugmakers
2026-07-06 09:40:11
Germany’s ruling coalition modified its cost-cutting reform bill for the country’s public health-insurance system to ease the financial impact on the pharmaceutical industry, according to Bloomberg.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
